LINC00702

Across TCGA pan-cancer cohorts, LINC00702 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC00702 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC00702 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00702 expression acts as an unfavorable survival marker, although some lineages such as LIHC and LUAD show a favorable association.

KIRP, UVM, and MESO are the cancer types where LINC00702 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.883	0.974	<.001	128	view →
UVM	DFS	Tertile	II,III,IV	0.531	0.898	<.001	85	view →
MESO	OS	Median	All	0.250	0.523	<.001	75	view →
BLCA	OS	Tertile	All	0.337	0.600	<.001	66	view →
CESC	OS	Tertile	III,IV	0.403	0.843	.001	54	view →
LAML	DFS	Median	All	0.244	0.519	<.001	54	view →
HNSC	OS	Tertile	All	0.689	0.821	.001	32	view →
LGG	OS	Tertile	All	0.376	0.556	<.001	31	view →
LIHC	OS	Tertile	All	0.832	0.702	.003	26	view →
STAD	DFS	Tertile	All	0.582	0.827	.006	20	view →
KICH	OS	Quartile	All	0.701	1.000	.017	17	view →
OV	DFS	Tertile	All	0.471	0.591	.006	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC00702–KIRP (OS)

Open the KIRP breakdown →